Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma.
D000328:Adult; D000368:Aged; D000619:Aminohydrolases / Q000378:metabolism; D001773:Blood Cells / Q000187:drug effects; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004247:DNA / Q000096:biosynthesis; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000201:enzymology; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010770:Phosphotransferases / Q000378:metabolism; D012737:Sex Factors; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D013997:Time Factors; D014316:Tritium
D003561:Cytarabine; D014316:Tritium; D004247:DNA; D010770:Phosphotransferases; D000619:Aminohydrolases